Vik Chopra

Q: What is Vik Chopra's success rate?

Vik Chopra currently has a success rate of 92.96492259455222.

Q: What is the average return of Vik Chopra's calls?

Their stock ratings have generated an average return of 11.90681392931079.

BMO Capital | Healthcare

Vik Chopra is an analyst from BMO Capital specializing in the Healthcare sector. Ranked #1622 out of 4773 analysts, they have issued 28 stock ratings with a success rate of 92.96% and an average return of 11.91%.

Vik Chopra has a well-established track record, with 28 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.96% and an average return of 11.91%, underscoring their expertise and ability to identify winning opportunities for investors.

#1622

Out of 4773

Total Ratings

+92.96%

Success Rate

+11.91%

Average Return

Recent Ratings Analysis

ATEC

Buy

Aug 05, 2026

Target

$12.00

Current

$8.84

Performance

-7.63%

Vik Chopra rated ATEC as Outperform on Aug 05, 2026, setting a price target of 12. The stock has underperformed, dropping 7.63% despite the bullish target of 12.

ALGN

Buy

Jul 09, 2026

Target

$209.00

Current

$150.72

Performance

-15.41%

On Jul 09, 2026, ALGN was given a Outperform rating by Vik Chopra, with a target price of 209. Despite the Buy call, shares fell from 150.72 to 150.72, challenging the optimistic stance.

ENOV

Buy

Jul 09, 2026

Target

$29.00

Current

$18.41

Performance

-27.00%

ENOV received a Outperform rating from Vik Chopra on Jul 09, 2026, aiming for 29. The rating hasn’t played out as hoped, with the stock trading 27.00% below expectations.

IART

Hold

Jul 09, 2026

Target

$19.00

Current

$15.54

Performance

-15.50%

On Jul 09, 2026, Vik Chopra published a Market Perform outlook on IART, with a target of 19. Weakness in the stock, now at 15.54, supported the conservative rating.

ISRG

Buy

Jul 09, 2026

Target

$518.00

Current

$360.46

Performance

-12.41%

Vik Chopra on Jul 09, 2026 assigned ISRG a Outperform rating, with a price target of 518. The call has struggled to gain traction, with shares losing 12.41%.

NVST

Hold

Jul 09, 2026

Target

$27.00

Current

$25.87

Performance

0.43%

On Jul 09, 2026, Vik Chopra reaffirmed NVST with a Market Perform rating, targeting 27. The neutral call matched muted market action of 0.43%.

TFX

Buy

Jul 09, 2026

Target

$159.00

Current

$132.00

Performance

-1.52%

TFX was rated Outperform by Vik Chopra on Jul 09, 2026, with a price objective of 159. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ZBH

Hold

Jul 09, 2026

Target

$95.00

Current

$92.44

Performance

3.60%

On Jul 09, 2026, Vik Chopra initiated coverage on ZBH with a Market Perform rating and target of 95. The stock’s lack of movement around 92.44 aligned with a cautious approach.

SOLV

Hold

Feb 27, 2026

Target

$86.00

Current

$87.65

Performance

18.13%

Vik Chopra issued a Equal-Weight recommendation for SOLV on Feb 27, 2026, price target set at 86. A neutral call gave way to stronger-than-expected performance, closing in on 86.

XRAY

Hold

Feb 27, 2026

Target

$13.00

Current

$10.50

Performance

-28.47%

On Feb 27, 2026, XRAY was evaluated by Vik Chopra, who gave a Equal-Weight rating and target of 13. The Hold call avoided chasing into subsequent weakness of 28.47%.

GMED

Buy

Feb 26, 2026

Target

$104.00

Current

$73.56

Performance

-23.94%

Vik Chopra rated GMED as Overweight on Feb 26, 2026, setting a price target of 104. The stock has underperformed, dropping 23.94% despite the bullish target of 104.

HSIC

Hold

Feb 25, 2026

Target

$87.00

Current

$87.30

Performance

6.58%

On Feb 25, 2026, HSIC was given a Equal-Weight rating by Vik Chopra, with a target price of 87. The stock rallied from 87.3 to 87.3 after the Hold rating, surprising to the upside.

MASI

Hold

Feb 18, 2026

Target

$190.00

Current

$179.95

Performance

2.47%

MASI received a Equal-Weight rating from Vik Chopra on Feb 18, 2026, aiming for 190. Shares remained flat at 179.95, aligning with the neutral rating.

CNMD

Hold

Jan 29, 2026

Target

$42.00

Current

$46.22

Performance

23.88%

On Jan 29, 2026, Vik Chopra published a Equal-Weight outlook on CNMD, with a target of 42. The Hold call missed some of the bullish momentum as shares advanced toward 42.

NPCE

Buy

Nov 05, 2025

Target

$16.00

Current

$13.87

Performance

6.86%

Vik Chopra on Nov 05, 2025 assigned NPCE a Overweight rating, with a price target of 16. The Buy call aligned well with market performance, producing a gain of 6.86%.

Frequency Asked Questions

Who is Vik Chopra?

Vik Chopra is an analyst from BMO Capital specializing in the Healthcare sector.

What is Vik Chopra's success rate?

Vik Chopra currently has a success rate of +92.96%.

How many ratings has Vik Chopra issued?

Vik Chopra has issued 28 stock ratings so far.

What is the average return of Vik Chopra's calls?

Their stock ratings have generated an average return of +11.91%.

What is Vik Chopra's ranking?

Vik Chopra is ranked #1622 out of 4773 analysts.

What types of ratings does Vik Chopra give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Vik Chopra?

You can follow Vik Chopra by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Vik Chopra?

Their latest rating was a Buy on ATEC issued on 2026-08-05.